糖尿病的血管并发症：损伤机制和保护因素。
Vascular complications of diabetes: mechanisms of injury and protective factors.
机构信息
Research Division, Joslin Diabetes Center, Boston, MA 02215, USA.
出版信息
Cell Metab. 2013 Jan 8;17(1):20-33. doi: 10.1016/j.cmet.2012.11.012.
Abstract
In patients with diabetes, atherosclerosis is the main reason for impaired life expectancy, and diabetic nephropathy and retinopathy are the largest contributors to end-stage renal disease and blindness, respectively. An improved therapeutic approach to combat diabetic vascular complications might include blocking mechanisms of injury as well as promoting protective or regenerating factors, for example by enhancing the action of insulin-regulated genes in endothelial cells, promoting gene programs leading to induction of antioxidant or anti-inflammatory factors, or improving the sensitivity to vascular cell survival factors. Such strategies could help prevent complications despite suboptimal metabolic control.
摘要
在糖尿病患者中，动脉粥样硬化是导致预期寿命缩短的主要原因，而糖尿病肾病和视网膜病变分别是导致终末期肾病和失明的最大原因。改善治疗方法以对抗糖尿病血管并发症可能包括阻断损伤机制以及促进保护或再生因子，例如通过增强内皮细胞中胰岛素调节基因的作用、促进导致诱导抗氧化或抗炎因子的基因程序，或改善对血管细胞存活因子的敏感性。即使代谢控制不理想，这些策略也有助于预防并发症。
相似文献
1
Vascular complications of diabetes: mechanisms of injury and protective factors.
Cell Metab. 2013 Jan 8;17(1):20-33. doi: 10.1016/j.cmet.2012.11.012.
2
Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy.
Curr Vasc Pharmacol. 2005 Jul;3(3):267-83. doi: 10.2174/1570161054368634.
3
The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
Cell Biochem Biophys. 2015 Apr;71(3):1425-43. doi: 10.1007/s12013-014-0365-y.
4
Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.
Curr Pharm Des. 2005;11(18):2279-99. doi: 10.2174/1381612054367300.
5
Oxidative stress in diabetic nephropathy.
Curr Med Chem. 2010;17(34):4256-69. doi: 10.2174/092986710793348581.
6
Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy.
J Endocrinol. 2014 Sep;222(3):R129-39. doi: 10.1530/JOE-14-0065. Epub 2014 Jun 13.
7
Diabetic nephropathy--prevalence, complications and treatment.
Diabet Med. 1985 Jan;2(1):7-12. doi: 10.1111/j.1464-5491.1985.tb00584.x.
8
Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy.
Curr Pharm Des. 2008;14(10):962-8. doi: 10.2174/138161208784139729.
9
Pigment epithelium-derived factor (PEDF): its potential therapeutic implication in diabetic vascular complications.
Curr Drug Targets. 2008 Nov;9(11):1025-9. doi: 10.2174/138945008786786154.
10
Clinical diabetic nephropathy: natural history and complications.
Clin Endocrinol Metab. 1986 Nov;15(4):783-805. doi: 10.1016/s0300-595x(86)80074-3.
引用本文的文献
1
Noninvasive Assessment of Arterial Wall and Soluble ST2 in Patients with Type 2 Diabetes and Coronary Artery Disease.
Int J Mol Sci. 2025 Aug 5;26(15):7561. doi: 10.3390/ijms26157561.
2
Daidzein alleviates renal damage in streptozotocin induced diabetes in Sprague Dawley rats by targeting NOX-4 and RAC-1.
J Mol Histol. 2025 Aug 12;56(5):266. doi: 10.1007/s10735-025-10430-6.
3
Relations of Life's Essential 8 Score with Arterial and Microvascular Function: The Jackson Heart Study.
medRxiv. 2025 Aug 3:2025.08.01.25332660. doi: 10.1101/2025.08.01.25332660.
4
Novel Function for Endothelial Protease-Activated Receptors in Modulating Insulin Receptor Activity With Implications for Diabetes.
Arterioscler Thromb Vasc Biol. 2025 Jul 31. doi: 10.1161/ATVBAHA.125.323140.
5
Cardiometabolic risk phenotypes and chronic kidney disease incidence in older adults: a nationwide longitudinal cohort study.
BMC Public Health. 2025 Jul 29;25(1):2581. doi: 10.1186/s12889-025-23868-w.
6
Therapeutic Plasma Exchange: Current and Emerging Applications to Mitigate Cellular Signaling in Disease.
Biomolecules. 2025 Jul 12;15(7):1000. doi: 10.3390/biom15071000.
7
Pathophysiological Mechanisms of Diabetes-Induced Macrovascular and Microvascular Complications: The Role of Oxidative Stress.
Med Sci (Basel). 2025 Jul 2;13(3):87. doi: 10.3390/medsci13030087.
8
Facile 3-chloro-1H-indazole based 1,3,4-thiadiazole derivatives as novel thymidine phosphorylase and anti-diabetic inhibitors: Experimental, in-vitro and molecular modelling approaches.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 19. doi: 10.1007/s00210-025-04385-4.
9
Facile indazole-endowed thiadiazole hybrid derivatives as antibacterial, anti-diabetic and thymidine phosphorylase inhibitors: An insight to experimental, in-vitro biological potential and computational approaches.
Saudi Pharm J. 2025 Jul 8;33(4):20. doi: 10.1007/s44446-025-00003-9.
10
Association between glycemia risk index and carotid intima-media thickness in type 2 diabetes.
Front Endocrinol (Lausanne). 2025 Jun 19;16:1563734. doi: 10.3389/fendo.2025.1563734. eCollection 2025.
本文引用的文献
1
Vegfa protects the glomerular microvasculature in diabetes.
Diabetes. 2012 Nov;61(11):2958-66. doi: 10.2337/db11-1655.
2
Wip1-dependent regulation of autophagy, obesity, and atherosclerosis.
Cell Metab. 2012 Jul 3;16(1):68-80. doi: 10.1016/j.cmet.2012.06.003.
3
Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.
Circ Res. 2012 May 11;110(10):1364-90. doi: 10.1161/CIRCRESAHA.111.243972.
4
Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.
FASEB J. 2012 Jul;26(7):2963-74. doi: 10.1096/fj.11-202994. Epub 2012 Apr 12.
5
Diabetic retinopathy.
N Engl J Med. 2012 Mar 29;366(13):1227-39. doi: 10.1056/NEJMra1005073.
6
Macrophage autophagy plays a protective role in advanced atherosclerosis.
Cell Metab. 2012 Apr 4;15(4):545-53. doi: 10.1016/j.cmet.2012.01.022. Epub 2012 Mar 22.
7
Protein kinase cβ phosphorylates occludin regulating tight junction trafficking in vascular endothelial growth factor-induced permeability in vivo.
Diabetes. 2012 Jun;61(6):1573-83. doi: 10.2337/db11-1367. Epub 2012 Mar 20.
8
Hyperinsulinemia does not change atherosclerosis development in apolipoprotein E null mice.
Arterioscler Thromb Vasc Biol. 2012 May;32(5):1124-31. doi: 10.1161/ATVBAHA.111.239558. Epub 2012 Mar 15.
9
A systems approach identifies HIPK2 as a key regulator of kidney fibrosis.
Nat Med. 2012 Mar 11;18(4):580-8. doi: 10.1038/nm.2685.
10
FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis.
Cell Metab. 2012 Mar 7;15(3):372-81. doi: 10.1016/j.cmet.2012.01.018.
Zotero 插件